DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Decoy receptor 1
Decoy receptor 1
Download
Download
TNF Decoy Receptors Encoded by Poxviruses
TRAIL and Cardiovascular Disease—A Risk Factor Or Risk Marker: a Systematic Review
Comprehensive Product List
Biolegend.Com
Differential Susceptibility to TRAIL of Normal Versus Malignant Human Urothelial Cells
Cell Structure & Function
The Concise Guide to Pharmacology 2019/20: Catalytic Receptors
Cell-Mediated and Cell Membrane-Coated Nanoparticles for Drug Delivery and Cancer Therapy
A Novel Fully Human Agonistic Single Chain Fragment Variable Antibody Targeting Death Receptor 5 with Potent Antitumor Activity in Vitro and in Vivo
TRAIL-Decoy Receptor-1 Disappears in Granulosa Cells of Atretic Follicles in Porcine Ovaries
Characterization of Chicken TNFR Superfamily Decoy Receptors, Dcr3 and Osteoprotegerinq
University of Groningen Probing the Ligand Receptor
Human CD263 / TRAIL-R3 ELISA Kit (ARG81333)
From Bones to Blood Pressure, Developing Novel Biologic Approaches Targeting the Osteoprotegein Pathway for Pulmonary Vascular Disease
Review Article TRAIL Modulates the Immune System and Protects Against the Development of Diabetes
Contribution of Epigenetic Silencing of Tumor Necrosis Factor–Related Apoptosis Inducing Ligand Receptor 1 (DR4) to TRAIL Resistance and Ovarian Cancer
Top View
Product List 2018 WE LIVE SERVICE Certificates
Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
Signal Transduction by Tumour Necrosis Factor and Tumour Necrosis Factor Related Ligands and Their Receptors
Development of CD40-Targeted Bifunctional Scfv-TRAIL Fusion Proteins That Induce TRAILR1- and TRAILR2-Specifc Cell Death and Dendritic Cells Activation
Micrornas As Regulators of Death Receptors Signaling
Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis
THE CONCISE GUIDE to PHARMACOLOGY 2017/18: Catalytic Receptors
Chemotherapy and TRAIL-Mediated Colon Cancer Cell Death: the Roles of P53, TRAIL Receptors, and C-FLIP
Plate Layout for Realtime Ready Human Apoptosis Panel, 96
Anti-CD263 / TRAIL R3 Antibody [1E12] (ARG58292)
(12) Ulllted States Patent (10) Patent N0.: US 8,007,813 B2 Walczak (45) Date of Patent: Aug
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
Changes in the Expression of Decoy Receptor 3 in Granulosa Cells
Catalytic Receptors
T-Ce11 Receptor Associated Signals That Modulate Lymphocyte Homeostasis
Following a TRAIL: Update on a Ligand and Its Five Receptors
DR5) Contribute Differently to TRAIL-Mediated Apoptosis
The Main La Millor La Mata Hatalantan